Kronos Bio, Inc. KRON

Set alert

Price alert · KRON

All alert types
0.88 0.00 0.00%

At close · Jun 20

0.8701 Day range 0.881

52-week range unavailable

Open
0.881
Prev close
0.88
Mkt cap
53.65M
Vol
53.69K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.8701
High
0.881
Forward P/E
-0.69
Beta
1.86
Short ratio
8.81
Inst. own
32.67%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
0.9384
200-d avg
1.04
1y target
2.25

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for KRON has not been loaded yet. Try again in a moment.

Analyst view

Price target (mean) 2.25
Ratings (0m) 2 1 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 3
  • 2 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

KRON analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.000.000.0%2.40M+5.0%0
Next quarter0.000.00 – 0.000.000.0%500.00K-80.2%0
Current year0.000.00 – 0.000.000.0%10.00M+59.0%0
Next year0.000.00 – 0.000.000.0%2.00M-80.0%0

Upgrades and downgrades

The latest rating changes

KRON analyst upgrades and downgrades
DateFirmActionFromTo
Aug 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 3, 2024HC Wainwright & Co.MaintainedBuyBuy
Dec 19, 2023Piper SandlerMaintainedOverweightOverweight
Dec 19, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 27, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 21, 2023HC Wainwright & Co.MaintainedBuyBuy
Apr 17, 2023HC Wainwright & Co.Reiterated—Buy
Nov 18, 2022HC Wainwright & Co.Maintained—Buy
Nov 10, 2022Goldman SachsMaintained—Buy
Nov 9, 2022Piper SandlerMaintained—Overweight
Sep 14, 2022BerenbergInitiated—Buy
May 24, 2022Goldman SachsMaintained—Buy
May 23, 2022Piper SandlerMaintained—Overweight
Feb 28, 2022Piper SandlerMaintained—Overweight
Nov 10, 2021HC Wainwright & Co.Maintained—Buy
Jun 24, 2021HC Wainwright & Co.Initiated—Buy
Nov 3, 2020Cowen & Co.Initiated—Outperform
Nov 3, 2020Goldman SachsInitiated—Buy
Nov 3, 2020Piper SandlerInitiated—Overweight